Semler Scientific Inc (SMLR)
23.77
+0.26
(+1.11%)
USD |
NASDAQ |
Sep 27, 16:00
23.86
+0.09
(+0.38%)
After-Hours: 20:00
Semler Scientific SG&A Expense (Annual): 32.44M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.44M |
| December 31, 2022 | 30.42M |
| December 31, 2021 | 23.68M |
| December 31, 2020 | 16.35M |
| December 31, 2019 | 15.92M |
| December 31, 2018 | 11.36M |
| December 31, 2017 | 8.921M |
| Date | Value |
|---|---|
| December 31, 2016 | 6.854M |
| December 31, 2015 | 11.14M |
| December 31, 2014 | 6.171M |
| December 31, 2013 | 3.573M |
| December 31, 2012 | 2.973M |
| December 31, 2011 | 1.704M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
15.92M
Minimum
2019
32.44M
Maximum
2023
23.76M
Average
23.68M
Median
2021
SG&A Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.06M |
| Retractable Technologies Inc | 20.01M |
| InfuSystems Holdings Inc | 58.03M |
| Xtant Medical Holdings Inc | 64.29M |
| Catheter Precision Inc | 17.12M |